Insights From HumanFirst Show Breadth of Pharmaceutical Inve

Insights From HumanFirst Show Breadth of Pharmaceutical Investment in AI/ML and Digital Endpoints in Clinical Trials

/PRNewswire/ -- Regulators are increasingly approving AI-powered endpoints using digital health technologies (DHTs) in drug development. To quantify this...

Related Keywords

Andy Coravos , Anita Nehru , Humanfirst Institute , First Institute , Humanfirst ,